A Phase II Study of Repeat Breast Preserving Surgery and 3D-Conformal Partial Breast Re-Irradiation (PBRI) for Local Recurrence of Breast Carcinoma
Principal Investigator
Douglas Arthur, MD
Status
Terminated
Date Opened To Accrual
June 04 2010
Date Closed to Accrual
June 18 2013
Date of Study Termination
May 20 2022
Disease Site
Breast [BR]
Breast
Phase
II
Developmental Therapeutics
No
Primary Objective
To evaluate skin, breast, and chest wall adverse events occurring within 1 year from the completion of re-irradiation.
Data Collection Notice:
Data for this trial is being collected via the NRG/RTOG Data Center.
Patient Population
- Histopathologic confirmation via lumpectomy of local in-breast ipsilateral recurrence
- Final breast surgery (lumpectomy and/or final re-excision) within 42 days prior to study entry;
- Initial lumpectomy followed by whole breast radiation >1 year prior to study entry;
- Bilateral breast mammogram and bilateral breast MRI within 120 days prior to study entry;
- Negative histologic margins of resection, no tumor on ink, following breast-preserving surgery of local recurrence
Target Accrual
61
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.